Mineralocorticoid Receptor Antagonist Pretreatment to MINIMISE Reperfusion Injury After ST-Elevation Myocardial Infarction (The MINIMISE STEMI Trial): Rationale and Study Design.

Bulluck, H; Fröhlich, GM; Mohdnazri, S; Gamma, RA; Davies, JR; Clesham, GJ; Sayer, JW; Aggarwal, RK; Tang, KH; Kelly, PA; +13 more... Jagathesan, R; Kabir, A; Robinson, NM; Sirker, A; Mathur, A; Blackman, DJ; Ariti, C; Krishnamurthy, A; White, SK; Meier, P; Moon, JC; Greenwood, JP; Hausenloy, DJ; (2015) Mineralocorticoid Receptor Antagonist Pretreatment to MINIMISE Reperfusion Injury After ST-Elevation Myocardial Infarction (The MINIMISE STEMI Trial): Rationale and Study Design. Clinical cardiology, 38 (5). pp. 259-66. ISSN 0160-9289 DOI: https://doi.org/10.1002/clc.22401

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1002/clc.22401

Abstract

Share

Download

Filename: Bulluck_et_al-2015-Clinical_Cardiology.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar